Monotone graph limits and quasimonotone graphs

The recent theory of graph limits gives a powerful framework for understanding the properties of suitable (convergent) sequences $(G_n)$ of graphs in terms of a limiting object which may be represented by a symmetric function $W$ on $[0,1]$, i.e., a kernel or graphon. In this context it is natural to wish to relate specific properties of the sequence to specific properties of the kernel. Here we show that the kernel is monotone (i.e., increasing in both variables) if and only if the sequence satisfies a `quasi-monotonicity' property defined by a certain functional tending to zero. As a tool we prove an inequality relating the cut and $L^1$ norms of kernels of the form $W_1-W_2$ with $W_1$ and $W_2$ monotone that may be of interest in its own right; no such inequality holds for general kernels.Comment: 38 page

Discriminating neutrino mass models using Type II seesaw formula

In this paper we propose a kind of natural selection which can discriminate the three possible neutrino mass models, namely the degenerate, inverted hierarchical and normal hierarchical models, using the framework of Type II seesaw formula. We arrive at a conclusion that the inverted hierarchical model appears to be most favourable whereas the normal hierarchical model follows next to it. The degenerate model is found to be most unfavourable. We use the hypothesis that those neutrino mass models in which Type I seesaw term dominates over the Type II left-handed Higgs triplet term are favoured to survive in nature.Comment: No change in the results, a few references added, some changes in Type[IIB] calculation

The NOX toolbox: validating the role of NADPH oxidases in physiology and disease

Reactive oxygen species (ROS) are cellular signals but also disease triggers; their relative excess (oxidative stress) or shortage (reductive stress) compared to reducing equivalents are potentially deleterious. This may explain why antioxidants fail to combat diseases that correlate with oxidative stress. Instead, targeting of disease-relevant enzymatic ROS sources that leaves physiological ROS signaling unaffected may be more beneficial. NADPH oxidases are the only known enzyme family with the sole function to produce ROS. Of the catalytic NADPH oxidase subunits (NOX), NOX4 is the most widely distributed isoform. We provide here a critical review of the currently available experimental tools to assess the role of NOX and especially NOX4, i.e. knock-out mice, siRNAs, antibodies, and pharmacological inhibitors. We then focus on the characterization of the small molecule NADPH oxidase inhibitor, VAS2870, in vitro and in vivo, its specificity, selectivity, and possible mechanism of action. Finally, we discuss the validation of NOX4 as a potential therapeutic target for indications including stroke, heart failure, and fibrosis